Aires-de-Sousa M, Ortiz de la Rosa JM, Gonçalves ML, Pereira AL, Nordmann P, Poirel L. 2019. Epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital, Portugal. Emerg Infect Dis 25:1632–1638. https://doi.org/10.3201/eid2509.190656.
Wachino J-i, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, Ito H, Arakawa Y. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A b-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob Agents Chemother 48:1960–1967. https://doi.org/10.1128/AAC.48.6.1960-1967 .2004.
Naas T, Dortet L, Iorga BI. 2016. Structural and functional aspects of class A carbapenemases. Curr Drug Targets 17:1006–1028. https://doi.org/10.2174/1389450117666160310144501.
Streling AP, Barbosa PP, Marcondes MF, Nicoletti AG, Picão RC, Pinto EC, Marques EA, Oliveira V, Gales AC. 2018. Genetic and biochemical characterization of GES-16, a new GES-type b-lactamase with carbapenemase activity in Serratia marcescens. Diagn Microbiol Infect Dis 92:147–151. https://doi.org/10.1016/j.diagmicrobio.2018.05.003.
Jeon JH, Lee JH, Lee JJ, Park KS, Karim AM, Lee CR, Jeong BC, Lee SH. 2015. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance. Int J Mol Sci 16:9654–9692. https://doi.org/10.3390/ijms16059654.
Smith CA, Frase H, Toth M, Kumarasiri M, Wiafe K, Munoz J, Mobashery S, Vakulenko SB. 2012. Structural basis for progression toward the carbapenemase activity in the GES family of b-lactamases. J Am Chem Soc 134:19512–19515. https://doi.org/10.1021/ja308197j.
Stewart NK, Smith CA, Frase H, Black DJ, Vakulenko SB. 2015. Kinetic and structural requirements for carbapenemase activity in GES-type b-lactamases. Biochemestry 54:588–597. https://doi.org/10.1021/bi501052t.
Kotsakis SD, Papagiannitsis CC, Tzelepi E, Legakis NJ, Miriagou V, Tzouvelekis LS. 2010. GES-13, a b-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa. Antimicrob Agents Chemother 54:1331–1333. https://doi.org/10.1128/AAC.01561-09.
Frase H, Toth M, Champion MM, Antunes NT, Vakulenko SB. 2011. Importance of position 170 in the inhibition of GES-type b-lactamases by clavulanic acid. Antimicrob Agents Chemother 55:1556–1562. https://doi.org/10.1128/AAC.01292-10.
Piccirilli A, Mercuri PS, Galleni M, Aschi M, Matagne A, Amicosante G, Perilli M. 2018. P174E substitution in GES-1 and GES-5 b-lactamases improves catalytic efficiency towards carbapenems. Antimicrob Agents Chemother 62:e01851-17. https://doi.org/10.1128/AAC.01851-17.
CLSI. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 11th ed. CLSI standard M07. Clinical and Laboratory Standards Institute, Wayne, PA.
De Meester F, Joris B, Reckinger G, Bellefroid-Bourguignon C, Frère JM, Waley SG. 1987. Automated analysis of enzyme inactivation phenomena. Application to b-lactamases and DD-peptidases. Biochem Pharmacol 36:2393–2403. https://doi.org/10.1016/0006-2952(87)90609-5.
Perilli M, Mancini A, Celenza G, Bottoni C, Bellio P, Sabatini A, Di Pietro L, Brisdelli F, Segatore B, Amicosante G. 2014. Kinetic study of the effect of histidines 240 and 164 on TEM-149 enzyme probed by b-lactam inhibitors. Antimicrob Agents Chemother 58:6294–6296. https://doi.org/10.1128/AAC.02950-14.
Tada T, Shrestha S, Shimada K, Ohara H, Sherchand JB, Pokhrel BM, Kirikae T. 2017. PER-8, a novel extended-spectrum b-lactamase PER variant, from an Acinetobacter baumannii clinical isolate in Nepal. Antimicrob Agents Chemother 61:e02300-16. https://doi.org/10.1128/AAC.02300-16.
Wachino J-i, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, Arakawa Y. 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A b-lactamase, GES-4, possessing a single G170S substitution in the X-loop. Antimicrob Agents Chemother 48:2905–2910. https://doi.org/10.1128/AAC.48.8.2905-2910.2004.
Smith CA, Caccamo M, Kantardjieff KA, Vakulenko S. 2007. Structure of GES-1 at atomic resolution: insights the evolution of carbapenemase activity in the class A extended-spectrum b-lactamases. Acta Crystallogr D Biol Crystallogr 63:982–992. https://doi.org/10.1107/S0907444907036955.
Krieger E, Vriend G. 2014. YASARA View—molecular graphics for all devices—from smartphones to workstations. Bioinformatics 30:2981–2982. https://doi.org/10.1093/bioinformatics/btu426.
Bebrone C, Bogaerts P, Delbrück H, Bennink S, Kupper MB, Rezende de Castro R, Glupczynski Y, Hoffmann KM. 2013. GES-18, a new carbapenem-hydrolyzing GES-type b-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues. Antimicrob Agents Chemother 57:396–401. https://doi.org/10.1128/AAC.01784-12.
CLSI. 2019. Susceptibility performance standards for antimicrobial testing, 29th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute, Wayne, PA.
